Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Epicutaneous Immunotherapy in Peanut Allergy

JAMA; ePub 2019 Feb 22; Fleischer, et al

Among children with peanut allergy, epicutaneous immunotherapy induced a statistically significant response compared with placebo in a phase 3, randomized, double-blind trial conducted at 31 sites in 5 countries. However, it did not meet the prespecified lower bound of the confidence interval (CI) criterion for a positive trial result. Participants included 356 peanut-allergic children aged 4-11 years without a history of a severe anaphylactic reaction developing objective symptoms during the double-blind, placebo-controlled food challenge at an eliciting dose of ≤300 mg of peanut protein. Interventions included daily treatment with peanut patch containing either 250 µg of peanut protein (n=238) or placebo (n=118) for 12 months. The primary outcome was the percentage difference in responders between the peanut patch and placebo patch based on eliciting dose. Researchers found:

  • Among 356 participants (median age 7 years, 61.2% male) randomized, 89.9% completed the trial with mean treatment adherence at 98.5%.
  • The responder rate was 35.3% with peanut-patch treatment vs 13.6% with placebo.
  • However, the prespecified lower bound of the CI threshold was not met.

Citation:

Fleischer DM, Greenhawt M, Sussman G, et al. Effect of epicutaneous immunotherapy vs placebo on reaction to peanut protein ingestion among children with peanut allergy: The PEPITES randomized clinical trial. [Published online ahead of print February 22, 2019]. JAMA. doi:10.1001/jama.2019.1113.

This Week's Must Reads

AHA Statement: Accurate Measurement of BP, Hypertension; ePub 2019 Mar 4; Muntner, et al

Coffee Consumption & Plasma Biomarkers, Am J Clin Nutr; ePub 2019 Mar 5; Hang, et al

Is Adding Aspirin to Warfarin Therapy Beneficial? , JAMA Intern Med; ePub 2019 Mar 4; Schaefer, et al

Urinary Oxalate Excretion & Risk of CKD Progression, JAMA Intern Med; ePub 2019 Mar 4; Waikar, et al

Psychosocial Stress & CV Health in Older Women, Circulation; ePub 2019 Feb 28; Burroughs-Peña, et al